PRACTICE: DECISIONS. Oral allergy syndrome
- Fall allergy season makes early entrance for patients. Levy, Sandra // Drug Topics;9/20/99, Vol. 143 Issue 18, p44
Lists several drugs to prevent and manage fall allergy in the United States. Signs and symptoms of fall allergy; Conditions ideal for ragweed, the major culprit in hay fever; Indication of the over-the-counter drug Children's NasalCrom from Pharmacia & Upjohn Consumer Healthcare division;...
- Allergen immunotherapy and asthma: Efficacy, safety, and other considerations. Cox, Linda // Allergy & Asthma Proceedings;Nov/Dec2008, Vol. 29 Issue 6, p580
The efficacy of allergen immunotherapy (AIT) for allergic asthma is often debated despite multiple controlled trails and three meta-analyses that have established a significant effect on subjective and objective outcomes. Indications for AIT in allergic asthma include suboptimal control with...
- Oxaliplatin/Viscum album extract. // Reactions Weekly;3/20/2010, Issue 1293, p38
The article describes the case of a 56-year-old man who developed hypersensitivity while undergoing chemotherapy with oxaliplatin. The patient has colon cancer and was subjected to adjuvant chemotherapy based on the FOLFOX-4 regimen. The patient also had worsened asthma following increased...
- Nature of Regulatory T Cells in the Context of Allergic Disease. Ozdemir, Cevdet; Akdis, Mübeccel; Akdis, Cezmi A. // Allergy, Asthma & Clinical Immunology;Fall2008, Vol. 4 Issue 3, p106
Allergen-specific immunotherapy (SIT) is the cornerstone of the management of allergic diseases, which targets modification of the immunologic response, along with environmental allergen avoidance and pharmacotherapy. SIT is associated with improved tolerance to allergen challenge, with a...
- ACUTE ALLERGIC CONJUNCTIVITIS. // Review of Optometry;3/15/2004 Supplement, Vol. 141, p17A
The article presents information on acute allergic conjunctivitis (AAC). AAC describes the abrupt and immediate response seen in sensitized individuals after exposure to a particular allergen or sensitizing agent. Two forms are recognized: seasonal allergic conjunctivitis, which coincides with...
- Allergy immunotherapy. // Reactions Weekly;Feb2014, Vol. 1489 Issue 1, p7
The article presents a case study of a 25-year old woman who developed systemic reactions, ocular pruritus and conjunctival injection during treatment with allergy immunotherapy.
- Sublingual immunotherapy approved for grass pollen allergies. Thompson, Cheryl A. // American Journal of Health-System Pharmacy;5/15/2014, Vol. 71 Issue 10, p770
The article talks about Oralair, the first sublingual immunotherapy alternative for immunotherapy injections for people 10 to 65 years old who suffer from grass pollen allergies manufactured by French pharmaceutical company Stallergenes, S.A. Oralair was approved by the U.S. Food and Drug...
- Allergy immunotherapy/grass pollen allergy immunotherapy. // Reactions Weekly;Sep2014, Vol. 1520 Issue 1, p16
The article presents a case study of a 10-year-old boy who experienced systemic allergic reaction after being administered with grass pollen allergy immunotherapy and allergy immunotherapy.
- Grass pollen allergy vaccine also effective against hepatitis B. // Operating Theatre Journal;Oct2016, Issue 313, p26
No abstract available.